ArticleNature medicine2023

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

Jeroen van Dorp et al.PubMed ↗Publisher ↗

No numbers read from the abstract.